Athena Countouriotis Insider Trading $IOVA IOVANCE BIOTHERAPEUTICS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Athena Countouriotis.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Athena Countouriotis. Athena Countouriotis is SVP and Chief Medical Officer in HALOZYME THERAPEUTICS INC ($GYHT) and Chief Medical Officer in AMBIT BIOSCIENCES CORP ($AMBI) and Director in Trovagene, Inc. ($XNOM.OB) and Director in IOVANCE BIOTHERAPEUTICS, INC. ($IOVA) and SVP, Chief Medical Officer in Adverum Biotechnologies, Inc. ($ADVM) and President & CEO in Turning Point Therapeutics, Inc. ($TPTX) and Director in Passage BIO, Inc. ($PASG).

Athena Countouriotis in IOVANCE BIOTHERAPEUTICS, INC.

Trading Symbol: IOVA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Athena Countouriotis: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 10 2020
$IOVA Market Capitalization: $437.71M
$IOVA Previous Close: $7.10

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Athena Countouriotis in IOVANCE BIOTHERAPEUTICS, INC.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ADVM, AMBI, XNOM.OB, GYHT, IOVA, PASG, TPTX

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 10 2020	IOVA	IOVANCE BIOTHERAPE ...	Countouriotis Athena	Director	Option Exercise	A	32.17	35,000	1,125,950	35,000
Jun 11 2019	IOVA	IOVANCE BIOTHERAPE ...	Countouriotis Athena	Director	Option Exercise	A	19.93	35,000	697,550	35,000

Page: 1